CorMedix Inc.
CRMD
$11.50
$1.4314.20%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 39.74M | 39.08M | 31.21M | 11.46M | 806.10K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 39.74M | 39.08M | 31.21M | 11.46M | 806.10K |
| Cost of Revenue | 1.86M | 1.60M | 1.18M | 686.60K | 509.80K |
| Gross Profit | 37.87M | 37.48M | 30.03M | 10.77M | 296.30K |
| SG&A Expenses | 15.89M | 14.17M | 15.37M | 13.33M | 14.95M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 20.19M | 18.96M | 18.27M | 14.74M | 16.11M |
| Operating Income | 19.54M | 20.13M | 12.94M | -3.29M | -15.30M |
| Income Before Tax | 20.35M | 20.64M | 13.46M | -2.78M | -14.15M |
| Income Tax Expenses | 521.50K | -- | 0.00 | -- | -- |
| Earnings from Continuing Operations | 19.83M | 20.64M | 13.46M | -2.78M | -14.15M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 19.83M | 20.64M | 13.46M | -2.78M | -14.15M |
| EBIT | 19.54M | 20.13M | 12.94M | -3.29M | -15.30M |
| EBITDA | 19.71M | 20.29M | 13.07M | -3.21M | -15.22M |
| EPS Basic | 0.29 | 0.32 | 0.22 | -0.05 | -0.25 |
| Normalized Basic EPS | 0.19 | 0.20 | 0.14 | -0.03 | -0.15 |
| EPS Diluted | 0.28 | 0.30 | 0.22 | -0.05 | -0.25 |
| Normalized Diluted EPS | 0.18 | 0.19 | 0.14 | -0.03 | -0.15 |
| Average Basic Shares Outstanding | 67.93M | 65.24M | 61.51M | 58.83M | 57.62M |
| Average Diluted Shares Outstanding | 71.92M | 68.98M | 61.51M | 58.83M | 57.62M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |